Tag Archives: after

Novartis’ Kisqali takes step back in heated market after NICE no vote

With sales of its breast cancer drug Kisqali lagging, Novartis saw an opening in the U.K. market to gain ground on its competitors. Now that door has swung shut. In draft guidance published Wednesday, the National Institute for Health and Care Excellence (NICE) chose not to recommend Kisqali (ribociclib) for treatment of women with hormone… Read More »

How to Take On Your Workouts After 40

Here’s how I became an expert on building muscle when you’re over 40: I turned 40. I started paying more attention to the many dishonest ways fitness in general, and strength training especially, is sold to men and women over 40. It starts with the generalization that everyone over 40 is in the same condition… Read More »